Physicist Séamus Davis has received a $2 million, five-year grant to explore new ways to study “quantum materials” like superconductors, superfluids and whatever comes next.
A first clinical trial of ultrasmall, multifunctional particles called "C dots" (Cornell dots) has deemed them safe for humans and cleared easily by the body.
The five-year, $2.29 million grant supports “exceptionally creative new investigators who propose highly innovative projects that have the potential for unusually high biomedical impact."
Scientists at the Cornell Laboratory for Accelerator-based Sciences and Education have been working for the last decade on research and development of an Energy Recovery Linac as a new X-ray light source. The research has led to the creation of a new particle accelerator, which offers a wide range of applications beyond the ERL.
Using a technique that illuminates subtle changes in individual proteins, chemistry researchers have uncovered new insight into the underlying causes of Amyotrophic Lateral Sclerosis.
